Product Information

VESTURA 3 MG-0.02 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1796 per EA under NDC 00093400062. Its NADAC has been published 267 times since Apr 21, 2021.

FDA first approved this application on Nov 28, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VESTURA 3 MG-0.02 MG TABLET

Drospirenone and Ethinyl Estradiol
$0.1796per EA
Discontinued

NDC

00093400062

Classification

Generic

Dosage Form

KIT

Effective Date

5/20/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078833

FDA Approved

11/28/2011

TE Code

AB

On Market Since

3/2/2021

Price Statistics

The NADAC for VESTURA 3 MG-0.02 MG TABLET has been published 267 times since Apr 21, 2021, and over the history we have for it it has declined 55.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1796 per EA
All-time high$0.4077 (Jan 12, 2022)
All-time low$0.1278 (Nov 20, 2024)
52-week high$0.1796
52-week low$0.1538
Median price$0.2534
Average price$0.2509
Largest weekly change-32.1% (Nov 20, 2024)
Weeks tracked267
Tracking sinceApr 21, 2021

Price History

1W

N/A

1M

N/A

3M

0.0%

6M

+8.1%

1Y

+12.6%

3Y

-33.1%

5Y

-47.7%

All

-55.5%

Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of VESTURA 3 MG-0.02 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VESTURA 3 MG-0.02 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1796 per EA (NDC 00093400062), effective May 27, 2026.

How has the price of VESTURA 3 MG-0.02 MG TABLET changed over time?

Over the history we have for it, the NADAC for VESTURA 3 MG-0.02 MG TABLET has declined 55.5%. It has been tracked across 267 weekly CMS publications since Apr 21, 2021.

What are the highest and lowest recorded NADAC prices for VESTURA 3 MG-0.02 MG TABLET?

Since Apr 21, 2021, the NADAC for VESTURA 3 MG-0.02 MG TABLET has ranged from a low of $0.1278 (Nov 20, 2024) to a high of $0.4077 (Jan 12, 2022), with a median of $0.2534 per EA.

Are there cheaper alternatives to VESTURA 3 MG-0.02 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZUMANDIMINE 3 MG-0.03 MG TAB, is $0.1492 per EA — about 17% below VESTURA 3 MG-0.02 MG TABLET.

Who manufactures VESTURA 3 MG-0.02 MG TABLET?

VESTURA 3 MG-0.02 MG TABLET (NDC 00093400062) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.